Breaking: Koforidua SECTECH School Bus Involved In An Accident On The Somanya-Asesieso RoadGhana: Coronavirus Cases Up To 68, Nation Cry Unto God in Fasting and PrayersMinisterial Vetting: Restoring Peace In Bawku Is My Top Priority – Interior Minister Designate Uncleared ECG Containers At Tema Harbour Cost Ghana GHC 1.5 Billion In Demurrage; Energy Minister Vows ReformsA/R: Swift GNFS Action Tackles Fire At Kejetia Market, Averts Greater DisasterMahama Govt Paid MMDCEs Only 8 Days As January Salary – Alhaji Bodinga LamentsUTAG, TUTAG Presents Comprehensive List Of Challenges In Ghana’s Higher Education Sector To The Vice PresidentGES Announces Approval For Procurement Of Essential Food Items For Schools60 Ministers Will Not Help Your Political Cause; Appoint More ministers – Afenyo Markin To MahamaMinisterial Vetting: I Will Review Recruitment Into Security Services – Interior Minister Designate E/R: Upper West Akim MP Calls For Enforcement Of Sand Winning BanE/R: NDC Supporters Lobby For Victor Smith For AppointmentSamira Bawumia Mentors MPA Students From Harvard UniversityZoomlion Staff Receives Cedis, US Dollars And Motorbike For Returning Found Money To OwnerPolice Officer Receives FIFA Referees BadgeJohn Ansah Elected New GHALCA Chairman
US-based pharmaceutical firm will soon conduct a clinical study in Kenya to develop a vaccine to protect against monkeypox and smallpox.
The clinical trials are expected to start in the first half of 2023 with the US firm Tonix Pharmaceuticals Holding Corp and the Kenya Medical Research Institute (KEMRI).
The announcement of the Nairobi vaccine trials cements Kenya as a vaccine research hub.
Source: Mybrytnewsroom.com
All Rights Reserved (c)2020 Joy Daddy Multimedia Powered By Global Network Consult Ltd.
